(redirected from Risk-adjusted Net Present Value)
rNPVRisk-adjusted Net Present Value
References in periodicals archive ?
EXHIBIT 1 In theory, a preclinical preference Theoretical distribution of licensing deals, (1) percent Preclinical phase 51 Clinical phases Phase I 23 Phase II 14 Phase III 7 File new-drug application 5 (1) Assumes deals that are completely "fair"--that is, pricing reflects risk-adjusted net present value of compound at all phases, with both parties indifferent as to when licensure occurs.
Full browser ?